Intralesional Mode of Drug Administration in Psoriasis.

Abstract

The use of various conventional systemic and topical therapies in psoriasis has resulted in various major and minor side effects. Hence, we need to switch to intralesional administration of antipsoriatic drugs, to achieve better safety and efficacy profile. Intralesional drug therapy is most suitable for scalp, nail, and localized and recalcitrant plaque psoriasis. However, there are specific drugs, which can be used for this purpose, under strict monitoring. We have attempted to review all the possible drugs and indications where intralesional administration is feasible, along with their efficacy, adverse effects, dosage, and recommended duration of treatment. J Drugs Dermatol. 2022;21(2):186-190. doi:10.36849/JDD.6196.

• Authors: Suja Sathyan, Komal Agarwal, Indrashis Podder, Anant Patil, Leon Kircik, Jeffrey Weinberg, Paul Yamauchi, Stephan Grabbe, Mohamad Goldust
• Journal: Journal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 21 Issue 2 Pg. 186-190 (Feb 01 2022) ISSN: 1545-9616 [Print] United States
• PMID: 35133110 (Publication Type: Journal Article)

Chemical References

• Dermatologic Agents
• Pharmaceutical Preparations

Topics

• Dermatologic Agents (adverse effects)
• Humans
• Nails
• Pharmaceutical Preparations
• Psoriasis (diagnosis, drug therapy)
• Scalp
• Treatment Outcome